We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Apyx Medical

Apyx Medical, formerly Bovie Medical, is an advanced energy technology company with a passion for elevating people’s ... read more Featured Products: More products

Download Mobile App




Plasma-Based Surgical Instrument Combines Cutting and Coagulation

By HospiMedica International staff writers
Posted on 12 Apr 2017
Print article
Image: The J-Plasma generator and hand piece (Photo courtesy of Bovie Medical).
Image: The J-Plasma generator and hand piece (Photo courtesy of Bovie Medical).
A novel device offers increased control of plasma stream tissue dissection, while being able to switch to a monopolar or helium spray coagulation mode with just the push of a button.

The Bovie Medical J-Plasma generator and handpiece with Cool-Coag technology utilizes helium ionization to produce a stable, focused beam of ionized gas that provides a highly defined, cool, plasma stream for soft tissue coagulation and cutting. The plasma stream, formed by passing inert helium over an energizing blade, can cut, coagulate, and ablate tissue at lower temperatures than CO2 lasers, allowing surgical procedures to be performed in delicate areas with reduced damage to surrounding tissue.

The distinctive blade design of the hand piece provides an option to retract or extend the surgical blade, with multiple modes of operation. In the extended configuration, the surgical blade can be used without energy or plasma, similar to a scalpel for incisions and other cutting procedures. When retracted, the device can be used to form the J-Plasma stream for coagulation or blunt dissection. The J-Plasma stream with the blade extended is limited to a maximum of 15mm in length, thus eliminating potential pass-through.

“The development of Bovie’s Cool-Coag technology is a direct result of feedback from surgeons who have used our J-Plasma product for procedures that require greater coagulation capability, specifically in the areas of gynecologic oncology and surgical oncology,” said Robert Gershon, CEO of Bovie Medical. “The unique flexibility of Cool-Coag enables the surgeon to use J-Plasma to perform the most delicate procedures, where precision and low risk of injury to surrounding tissue are paramount and also have the full power of monopolar coagulation to control, pinpoint and diffuse bleeding as needed.”

“This new Cool-Coag technology has the potential to increase usage of the J-Plasma device in many of our most complex cancer procedures. It combines J-Plasma’s ability to be used close to vital structures with minimal collateral damage and standard full monopolar coagulation capability, all in one hand-held instrument,” said Dennis Chi, MD, head of ovarian cancer surgery at Memorial Sloan Kettering Cancer Center (MSKCC; New York, NY, USA). “Cool-Coag may also expand the use of J-Plasma in additional procedures and specialties.”

Plasma is one of the four fundamental states of matter, the others being solid, liquid, and gas. When a gas is ionized, electrons are stripped from its atoms, turning it into plasma. The plasma contains charged particles: positive ions and negative electrons or ions, accompanied by dissociation of the atomic bonds. Plasma has so far enjoyed a limited role in surgery due to the high temperatures it creates and resulting harmful effects on body tissue.

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Transcatheter Heart Valve
SAPIEN 3 Ultra
New
Plasma Freezer
iBF125-GX

Print article

Channels

Critical Care

view channel
Image: Changes in immune cells can predict patient recovery following out-of-hospital cardiac arrest (Photo courtesy of Adobe Stock)

Activating T Cells Could Improve Neurological Outcomes After Cardiac Arrest

Despite advancements in cardiopulmonary resuscitation (CPR) and improved hospital access, survival rates after out-of-hospital cardiac arrest (OHCA) remain low, with only about 10% of patients surviving.... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.